Learn more

NABRIVA THERAPEUTICS AG

Overview
  • Total Patents
    139
  • GoodIP Patent Rank
    111,969
  • Filing trend
    ⇩ 100.0%
About

NABRIVA THERAPEUTICS AG has a total of 139 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), China and Taiwan. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are CORSAIR PHARMA INC, MERRELL TORAUDE & CO and BYK NEDERLAND BV.

Patent filings per year

Chart showing NABRIVA THERAPEUTICS AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Heilmayer Werner 78
#2 Riedl Rosemarie 34
#3 Mang Rosemarie 33
#4 Novak Rodger 25
#5 Thirring Klaus 25
#6 Spence Lee 24
#7 Bulusu Atchyuta Rama Chandra Murty 24
#8 Ferencic Mathias 21
#9 Ascher Gerd 20
#10 Strickmann Dirk 19

Latest patents

Publication Filing date Title
EP2433926A1 Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes
MX2010009451A Pleuromutilin derivatives for the treatment of diseases mediated by microbes.
WO2011032192A1 Substituted clavulanic acid
EP2399904A1 Process for the preparation of pleuromutilins
EP2390245A1 Enantiomerically pure amines
EP2159220A1 Organic compounds
EP2014645A1 Pleuromutilin derivatives and their use as antimicrobials
EP2014640A1 Pleuromutilin derivatives
EP1972618A1 Pleuromutilin derivatives for the treatment of diseases mediated by microbes